Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Cancer|February 27, 2008
UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinomaChun-Yu Liu, Po-Min Chen, Tzeon-Jye Chiou, et al.The Oncologist|April 5, 2007
Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patientsWei-Shu Wang, Jen-Kou Lin, Tzu-Chen Lin, et al.Leukemia & Lymphoma|December 29, 2004
Overexpression of cyclin D1 in accelerated-phase chronic myeloid leukemiaJin-Hwang Liu, Chueh-Chuan Yen, Yu-Chen Lin, et al.Advances in Therapy|April 3, 2004
All-trans retinoid acid increases Notch1 transcript expression in acute promyelocytic leukemiaJen-Tsun Lin, Ming-Shiuan Wu, Wei-Shu Wang, et al.Cancer|August 14, 2002
Low incidence of BCL-6 gene alterations for diffuse large B-cell lymphomas in Taiwan ChinesePo-Min Chen, Muh-Hwa Yang, I-Ting Yu, et al.Journal of the Chinese Medical Association : JCMA|January 29, 2013
Bacterial pneumonia following acute ischemic strokeLi-Fu Chen, Cheng-Yu Chang, Li-Cho Hsu, et al.Urology|February 9, 2002
Prognostic-factors-based risk-stratification model for invasive urothelial carcinoma of the urinary bladder in TaiwanMuh Hwa Yang, Chueh Chuan Yen, Po Min Chen, et al.International Journal of Oncology|August 13, 2008
Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcomePeter Mu-Hsin Chang, Po-Min Chen, Shie-Liang Hsieh, et al.Urology|May 7, 2002
Unusually high incidence of upper urinary tract urothelial carcinoma in TaiwanMuh-Hwa Yang, Kuang-Kuo Chen, Chueh-Chuan Yen, et al.Investigational New Drugs|March 4, 2005
Paclitaxel in a novel formulation containing less Cremophor EL as first-line therapy for advanced breast cancer: a phase II trialTa-Chung Chao, Zyting Chu, Ling-Ming Tseng, et al.Pageof 9